Go to deals
Private Equity | Healthcare

Monument MicroCap Partners has sold Montgomery DME to Incline Equity Partners

Monument MicroCap Partners, LLC (MMP) has sold Montgomery DME (MDME) to Incline Equity Partners.

MDME is a leading provider of durable medical equipment rentals to the hospice market, including beds, oxygen systems, wheelchairs and bath safety products. The company acts as a critical extension of its hospice partners, providing full-service equipment delivery and maintenance through its highly trained technicians, enabling hospice agencies to focus on their core caregiving competencies. MDME’s five strategically located facilities enable the company to serve over 400 hospice agencies annually throughout southern California.

Incline Equity Partners, headquartered in Pittsburgh, Pennsylvania, is a private equity firm investing in manufacturing, distribution and business services companies. The firm seeks growing companies with enterprise values of US$25–750 million. Incline’s typical investment types are ownership transitions for privately held businesses, buy-outs and corporate divestitures within the US and Canada.

MMP is an independent private investment firm comprised of highly experienced and accomplished private equity and operational executives seeking to sponsor the acquisition of companies in the microcap market, which they define as companies with an EBITDA between US$2–8 million. Its focus is on businesses located in the US and Canada.

Oaklins TM Capital in the US served as the exclusive financial advisor to Montgomery DME, a portfolio company of Monument MicroCap Partners, in its sale to Incline Equity Partners.

Service
M&A sell-side
Parties
“In choosing a financial advisor, Monument sought a firm that would not only engineer an exceptional outcome for its shareholders, but would also appreciate MDME’s culture of compassionate care and identify the right partner to support the company’s future growth. Through every step of the process, it rang clear that Monument made the right choice, given TM Capital’s extensive healthcare expertise, superior execution, senior level attention and relentless dedication. We sincerely appreciate our relationship with the team and the value that they have delivered consistently for decades.”

Glenn Scolnik

Chairman and Founding Partner, Monument MicroCap Partners, LLC

Talk to the deal team

 Paul R. Smolevitz

Paul R. Smolevitz

Managing Director
New York, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital
 James  McLaren

James McLaren

Managing Director
New York, United States
Oaklins TM Capital
 John  Dean

John Dean

Associate Director
Atlanta, United States
Oaklins TM Capital
 Michael  Sanseverino

Michael Sanseverino

Analyst
New York, United States
Oaklins TM Capital
 Maxx  Trotsky

Maxx Trotsky

Analyst
New York, United States
Oaklins TM Capital

Related deals

Naish has been acquired by Kubus Sports
Private Equity | Consumer & Retail

Naish has been acquired by Kubus Sports

Kubus Sports has acquired Naish.

Learn more
MBI Healthcare Technologies has been acquired by DNV AS
Healthcare | TMT

MBI Healthcare Technologies has been acquired by DNV AS

The founders of MBI Healthcare Technologies have sold the company to DNV AS. The acquisition forms part of DNV’s strategic expansion into the digital health market, where it aims to significantly grow its presence through innovation, acquisitions, and partnerships. DNV and MBI will work to rapidly scale MBI’s solutions in the UK, target growth in international markets and bring new data assurance technologies to the healthcare sector.

Learn more
SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more